Abstract

BackgroundHypoxia and inflammation have been identified as hallmarks of cancer. A majority of hepatocellular carcinomas are preceded by hepatitis B- or C-related chronic infections suggesting that liver cancer development is promoted by an inflammatory microenvironment. The inflammatory cytokine oncostatin M (OSM) was shown to induce the expression of hypoxia-inducible factor-1 α (HIF-1 α) under normoxic conditions in hepatocytes and hepatoma cells. HIF-1 α is known to orchestrate the expression of numerous genes, many of which code for metabolic enzymes that play key roles in the adaptation of cellular metabolism to low oxygen tension.ResultsHere, we show that OSM-induced upregulation of HIF-1 α reprograms cellular metabolism in three clones of the human hepatocyte cell line PH5CH (PH5CH1, PH5CH7, and PH5CH8) towards a hypoxia-like metabolic phenotype but has no significant effect on cellular metabolism of HepG2 and JHH-4 hepatoma cells. Although we observed only minor changes in glucose uptake and lactate secretion in PH5CH8 upon OSM treatment, we identified more pronounced changes in intracellular fluxes based on stable isotope labeling experiments. In particular, glucose oxidation in the tricarboxylic acid (TCA) cycle is reduced through pyruvate dehydrogenase kinase 1 (PDK1)-mediated inhibition of the pyruvate dehydrogenase complex, thereby reducing the oxidative TCA cycle flux. As a result of the impaired mitochondrial glucose and glutamine oxidation, the reductive isocitrate dehydrogenase flux was increased.ConclusionsWe provide evidence that connects the inflammatory mediator OSM to a hypoxia-like metabolic phenotype. In the human hepatocyte cell line PH5CH, OSM-mediated upregulation of HIF-1 α and PDK1 can induce hypoxia-like metabolic changes, although to a lesser extent than hypoxia itself. Since PDK1 is overexpressed in several cancers, it might provide a causal link between chronic inflammation and malignant cellular transformation.Electronic supplementary materialThe online version of this article (doi:10.1186/s40170-016-0141-0) contains supplementary material, which is available to authorized users.

Highlights

  • IntroductionA majority of hepatocellular carcinomas are preceded by hepatitis B- or C-related chronic infections suggesting that liver cancer development is promoted by an inflammatory microenvironment

  • Hypoxia and inflammation have been identified as hallmarks of cancer

  • Based on our previous finding that oncostatin M (OSM) mediates hypoxia-inducible factor-1α (HIF-1α) upregulation through increased mRNA and protein levels in a STAT3-dependent manner, we aimed to investigate the effects of OSM stimulation on central carbon metabolism in hepatocytes and hepatoma cells

Read more

Summary

Introduction

A majority of hepatocellular carcinomas are preceded by hepatitis B- or C-related chronic infections suggesting that liver cancer development is promoted by an inflammatory microenvironment. The inflammatory cytokine oncostatin M (OSM) was shown to induce the expression of hypoxia-inducible factor-1α (HIF-1α) under normoxic conditions in hepatocytes and hepatoma cells. Interleukin 6 (IL6)-type cytokines such as oncostatin M (OSM) are key players in the regulation of the immune response, the immune surveillance of tumor cells, and in the development of cancer [1]. Aberrant IL6 signaling is likewise able to induce a state of chronic inflammation, as observed in many cancer types and inflammatory diseases. Since hepatocellular carcinoma (HCC) development can be promoted by an inflammatory microenvironment, aberrant IL6 signaling is implicated in the onset of HCC [4, 5]. A direct link between IL6 and the onset of HCC was shown in a study by Naugleret et al, where male IL6 knockout mice

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call